|
TCRX Tscan Therapeutics Inc 1783328 |
| Balance Sheet |
|
Current Assets
|
292,722,000 |
|
Assets
|
371,118,000 |
|
Current Liabilities
|
35,956,000 |
|
Liabilities
|
130,148,000 |
|
Equity
|
240,970,000 |
|
Shares Out
|
48,697,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-110,822,000 |
|
Investing Cash Flow
|
-52,613,000 |
| Market Analysis |
Market Cap
|
295,594,134 |
|
Price
|
1.60 |
|
BVPS
|
4.95 |
|
PB
|
0.33 |
|
EPS
|
-1.05 |
|
PS
|
26.24 |
|
FCF
|
-163,435,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view TCRX documents filed with the SEC.
TCRX Filings
Clear
